Plantago ovata consumption and colorectal mortality in Spain, 1995-2000

Journal of Epidemiology

Volumn 19, Issue 4, 2009, Pages 206-211

  López, José Carlos ^a   Villanueva, Rosa ^a   Martínez Hernández, David ^a   Albaladejo, Romana ^a   Regidor, Enrique ^a   Calle, María Elisa ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Colorectal cancer; Ecological study; Plantago ovata; Population study

Indexed keywords

ISPAGULA; PROTECTIVE AGENT;

ARTICLE; COLORECTAL TUMOR; DEMOGRAPHY; DIET; DIETARY FIBER; FEMALE; GEOGRAPHY; HEALTH STATUS; HUMAN; LIFESTYLE; MALE; MORTALITY; PLANTAGO; SPAIN;

COLORECTAL NEOPLASMS; DEMOGRAPHY; DIET; DIETARY FIBER; FEMALE; GEOGRAPHY; HEALTH STATUS; HUMANS; LIFE STYLE; MALE; PLANTAGO; PROTECTIVE AGENTS; PSYLLIUM; SPAIN;

EID: 68549132394     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20080059     Document Type: Article

References (42)

1. López Abente G, Pollán M, Escolar A, Errezola M, Abraira V. Atlas of Cancer Mortality and other causes of Death in Spain 1978-1992. Fundacion Cientíca de la Asociación Española Contra el Cáncer. Madrid 1996.
2. López-Abente G, Pollán M, Aragonés N, Pérez-Gómez B, Hernández V, Lope V, et al. Plan Integral del Cáncer: Situación del cáncer en España. Madrid: Ministerio de Sanidad y Consumo. 2005.
3. Centro Nacional de Epidemiología. Área de Epidemiología Ambiental y Cáncer. Mortalidad por Cáncer en España, 2000. Available at: http://cne.isciii.es/cancer/mort2000.txt.
4. World Cancer Research Fund, American Institute for Cancer Research. The Second Expert Report. Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. Available at: http://www.dietandcancerreport.org, 2007.
5. Trowell H. The development of the concept of dietary ber in human nutrition. Am J Clin Nutr. 1978;31:S3-11.
6. Burkitt DP, Walker AR, Painter NS. Dietary ber and disease. JAMA. 1974;229(8):1068-74.
7. Food and Drug Administration (FDA) news. P04-100, November 2004.
8. Ficha técnica de Plantaben®, Diciembre 2001. Laboratorio MADAUS S.A.
9. Pastors JG, Blaisdell PW, Balm TK, Asplin CM, Pohl SL. Psyllium ber reduces rise in postpandrial glucose and insulin concentrations in patients with non-insulin-dependent diabetes. Am J Clin Nutr. 1991;53:1431-5.
10. Lupton JR. Is ber protective against colon cancer? Where the research is leading us. Nutrition. 2000;16:558-61.
11. Gelissen IC, Brodie B, Eastwood MA. Effect of Plantago ovata (psyllium) husk and seeds on sterol metabolism: studies in normal and ileostomy subjects. Am J Clin Nutr. 1994;59:395-400.
12. Juarranz M, Calle-Purón ME, González-Navarro A, Regidor-Poyatos E, Soriano T, Martínez-Hernandez D, et al. Physical exercise, use of Plantago ovata and aspirin, and reduced risk of colon cancer. Eur J Cancer Prev. 2002;11(5):465-72.
13. Instituto Nacional de Estadística (INE). Defunciones por provincia, edad y sexo 1995-2000. Available at: http://www.ine.es/inebmem/indice.htm.
14. Agencia Española del Medicamento y Productos Sanitarios. Available at: http://www.agemed.es/aplicaciones/home.htm.
15. Instituto Nacional de Estadística. Encuesta sobre Discapacidades, Deciencias y Estado de Salud 1999. Madrid: INE. 2002.
16. Monge-Corella S, García-Pérez J, Aragonés N, Pollán M, Pérez-Gómez B, López-Abente G. Lung cancer mortality in towns near paper, pulp and board industries in Spain: a point source pollution study. BMC Public Health. 2008;8:288.
17. Cordier S, Monfort C, Miossec L, Richardson S, Belin C. Ecological analysis of digestive cancer mortality related to contamination by diarrhetic shellsh poisoning toxins along the coasts of France. Environ Res. 2000;84:145-50.
18. Marque S, Jacqmin-Gadda H, Dartigues JF, Commenges D. Cardiovascular mortality and calcium and magnesium in drinking water: an ecological study in elderly people. Eur J Epidemiol. 2003;18:305-9.
19. a ed). University Press, New York: Oxford. 1998.
20. Bolúmar F, Vioque J, Rebagliato M. Estudios descriptivos ecológicos. Estudios transversales. In Medicina Preventiva y Salud Pública (ed Piédrola Gil); Masson, Barcelona, 2001: 87-100.
21. Giovannucci E. Modiable risk factors for colon cancer. Gastroenterol Clin North Am. 2002;31:925-43.
22. Giovannucci E. Obesity, gender and colon cancer. Gut. 2002;51:147.
23. González CA, Navarro C, Martínez C, Quirós JR, Dorronsoro M, Barricarte A, et al. El estudio prospectivo europeo sobre cáncer y nutrición (EPIC). Rev Esp Salud Publica. 2004;78:167-76.
24. IARC Working Group on the Evaluation of Cancer-Preventive Agents. Weight control and physical activity. Handbooks of cancer prevention, vol. 6. Lyon: IARC Press. 2002.
25. You WC, Jin F, Devesa S, Schatzkin A, Yang G, Rosenberg P, et al. Rapid increase in colorectal cancer rates in urban Shangai, 1972-97, in relation to dietary changes. J Cancer Epidemiol Prev. 2002;7(3):143-6.
26. Kono S. Secular trend of colon cancer incidence y mortality in relation to fat and meat intake in Japan. Eur J Cancer Prev. 2004;13:127-32.
27. Wynder EL, Cohen LA, Winters RD. The challenges of assessing fat intake in cancer research investigations. J Am Diet Assoc. 1997;97(S):S5-S8.
28. Bingham SA. Diet and colorectal cancer prevention. Biochem Soc Trans. 2000;28:12-6.
29. Pylkas AM, Juneja LR, Slavin JL. Comparison of different bers for in vitro production of short chain fatty acids by intestinal microora. J Med Food. 2005;8:113-6.
30. Bingham SA, Day NE, Luben R, Ferrari P, Simani N, Norat T, et al. Dietary ber in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition: an observational study. Lancet. 2003;361:1496-501.
31. Alabaster O, Tang Z, Shivapurkar N. Dietary ber and the chemopreventive modelation of colon carcinogenesis. Mutat Res. 1996;350:185-97.
32. Jacobs LR. Relationship between dietary bre and cancer: metabolic, physiologic, and cellular mechanisms. Proc Soc Exp Biol Med. 1986;183:299-310.
33. Clausen MR, Bonnen H, Mortensen PB. Colonic fermentation of dietary ber to short chain fatty acids in patients with adenomatous polyps and colonic cancer. Gut. 1991;32:923-8.
34. Donaldson MS. Nutrition and cancer: a review of the evidence for anticancer diet. Nutr J. 2004;3:19-40.
35. Woods SE, Basho S, Engel A. The inuence of gender on colorectal cancer stage: the state of Ohio, 1996-2001. J Womens Health. 2006;15:877-81.
36. Wakai K, Hirose K, Matsuo K, Ito H, Kuriki K, Suzuki T, et al. Dietary Risk Factors for Colon and Rectal Cancers: a comparative case-control study. J Epidemiol. 2006;16:125-35.
37. Quinn MJ, d'Onofrio A, Moller B, Black C, Martínez-García, Moller H, et al. Cancer mortality trends in the EU and acceding countries up to 2015. Ann Oncol. 2003;14:1148-52.
38. Sun Y, Li Y. Induction of β-glucuronidase activity during dimetylhhydrazine and additive effects of cholic acid and indole. Cancer Lett. 1988;39:69-76.
39. Nordgaard I, Hove H, Claisen MR, Mortensend PB. Colonic production of butyrate in patients with previous colonic cancer during long-term treatment with dietary bre (Plantago ovata seeds). Scand J Gastroenterol. 1996;31:1011-20.
40. Fernandez-Bañares F, Hinojosa J, Sánchez-Lombrana JL, Navarro E, Martínez-Salmerón JF, García-Pugés, et al. Randomized clinical trial of Plantago ovata seeds (dietary ber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Am J Gastroenterol. 1999;94:427-33.
41. Rodriguez-Cabezas ME, Gálvez J, Lorente MD, Concha A, Camuesco D, Azzouz S, et al. Dietary ber down-regulates colonic tumor necrosis factor-( and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats. J Nutr. 2002;132:3263-71.
42. Plantago ovata (Psyllium). Altern Med Rev. 2002;7:155-9.